Posterolateral fusion vs. interbody fusion for degenerative spondylolisthesis: 5 key notes

A new study published in Spine compares posterolateral fusion with interbody fusion for patients with degenerative spondylolisthesis.

Advertisement

Researchers conducted a systematic review of 865 articles gathered from PubMed, Cochrane and Embase. A two-reviewer assessment found five articles that matched inclusion criteria for the analysis. The researchers found:

 

1. Combination effect size was in favor of posterolateral fusion for length of stay.

 

2. There was no difference in fusion rate or operative time between the two techniques. Estimated blood loss was similar for both groups.

 

3. Posterolateral fusion and interbody fusion patients reported similar Oswestry Disability index scores, Short Form-36 scores and visual analog scale scores. The complication rate was similar between both groups of patients.

 

4. The researchers didn’t detect a publication bias in the articles and a sensitivity analysis validated the results.

 

5. The researchers concluded, “Patients with degenerative spondylolisthesis can be effectively managed with either PLF or IBF with no significant differences in clinical outcomes or fusion rate between the two groups.”

 

More articles on spine surgery:
6 key notes on patients with top VAS scores: Are they different?
Should spine surgeons extend multilevel posterior cervical decompression and fusions to T1? 5 key notes
10 spine surgeons on advising their patients about experimental therapies

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spine

Advertisement

Comments are closed.